Call +1 289-812-0046

Take part
in the Cold Urticaria
Clinical Trial


We invite you to take part in our clinical trial if you suffer from 

Chronic Inducible Cold Urticaria (ColdU)

despite using H1 antihistamine treatment.

What is the EFC16720 Chronic Inducible
Cold Urticaria Clinical Research Study?

EFC16720 is a clinical research study conducted by Canadian dermatology doctors to determine if the study medication can reduce itchy wheals and angioedema, symptoms that affect the quality of life of those suffering from Chronic Inducible Cold Urticaria (ColdU).

How Will EFC16720 Study Work?

Participants in this study will receive either the study medication or placebo. You have a 1 in 2 chance of receiving a placebo only in this study. By enrolling in this study, you will receive all study-related medical care at no cost to you. Also, you will be seen by a doctor who will closely watch your Chronic Inducible Cold Urticaria (ColdU).

You may receive a reimbursement up to $75.00 for study-related expenses for each visit.

Study Approved by

FAQs

Chronic Inducible Cold Urticaria (ColdU) causes pruritic wheals and/or angioedema when exposed to cold. Patients with Chronic Inducible Cold Urticaria (ColdU) experience systemic reactions, including anaphylaxis. There is no approved treatment available to date for Chronic Inducible ColdU.

Clinical research studies demonstrate a medication’s efficacy and safety. Qualified doctors run clinical research studies. The doctors are in charge of the study-related care of the participants. Independent committees (Institutional Review Boards or IRBs) also monitor clinical research studies to ensure participants are informed and protected.

Millions of people enroll in clinical research studies every year. A clinical research study may offer them choices when current treatments are not as helpful as hoped/expected. By enrolling in this study, you will receive all study-related medical care at no cost to you. Also, you will be seen by a doctor who will closely watch your Chronic Inducible Cold Urticaria (ColdU). 

You may be eligible if you are between 12 and 80 years old and have the presence of itchy wheals and/or angioedema due to cold despite the use of H1 antihistamine treatment.

Contact Us to See if You Qualify

Contact us to receive more information about this study and see if you qualify.